These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509 [TBL] [Abstract][Full Text] [Related]
3. Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Ongerboer de Visser BW; Somers R; Nooyen WH; van Heerde P; Hart AA; McVie JG Neurology; 1983 Dec; 33(12):1565-72. PubMed ID: 6685829 [TBL] [Abstract][Full Text] [Related]
4. Current status of intrathecal chemotherapy for human meningeal neoplasms. Bleyer WA Natl Cancer Inst Monogr; 1977 Dec; 46():171-8. PubMed ID: 580638 [TBL] [Abstract][Full Text] [Related]
6. Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. Allen JC; Rosen G; Mehta BM; Horten B Cancer Treat Rep; 1980; 64(12):1261-73. PubMed ID: 6970616 [TBL] [Abstract][Full Text] [Related]
7. Early blindness and coma during intrathecal chemotherapy for meningeal carcinomatosis. Boogerd W; Moffie D; Smets LA Cancer; 1990 Feb; 65(3):452-7. PubMed ID: 2297635 [TBL] [Abstract][Full Text] [Related]
8. Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy: A Retrospective Observational Study. Kim KH; Park M; Park EY; Gwak HS; Kim SH; Seo JW; Hyun JW; Kim HJ; Dho YS; Shin SH; Yoo H; Chang Wang K Neurology; 2024 Mar; 102(5):e209167. PubMed ID: 38364192 [TBL] [Abstract][Full Text] [Related]
9. Interventricular methotrexate therapy for carcinomatous meningitis due to breast cancer: a case with leukoencephalopathy. Hara H; Igarashi A; Yano Y; Yashiro T; Ueno E; Aiyoshi Y Breast Cancer; 2000; 7(3):247-51. PubMed ID: 11029806 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis. Tetef ML; Margolin KA; Doroshow JH; Akman S; Leong LA; Morgan RJ; Raschko JW; Slatkin N; Somlo G; Longmate JA; Carroll MI; Newman EM Cancer Chemother Pharmacol; 2000; 46(1):19-26. PubMed ID: 10912573 [TBL] [Abstract][Full Text] [Related]
11. MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy. Oka M; Terae S; Kobayashi R; Sawamura Y; Kudoh K; Tha KK; Yoshida M; Kaneda M; Suzuki Y; Miyasaka K Neuroradiology; 2003 Jul; 45(7):493-7. PubMed ID: 12761601 [TBL] [Abstract][Full Text] [Related]
12. Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: a pilot study in 13 patients. Nakagawa H; Fujita T; Kubo S; Izumoto S; Nakajima Y; Tsuruzono K; Tokiyoshi K; Hayakawa T Surg Neurol; 1996 Mar; 45(3):256-64. PubMed ID: 8638223 [TBL] [Abstract][Full Text] [Related]
13. Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukemia and lymphoma. Sakamaki H; Onozawa Y; Yano Y; Imai K; Sasaki T; Ibuka T; Funada N; Matsuda T Radiat Med; 1993; 11(4):146-53. PubMed ID: 8234858 [TBL] [Abstract][Full Text] [Related]
14. Brain lesions following combined treatment with methotrexate and craniospinal irradiation. Cruz-Sanchez FF; Artigas J; Cervos-Navarro J; Rossi ML; Ferszt R J Neurooncol; 1991 Apr; 10(2):165-71. PubMed ID: 1895163 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of patients with meningeal carcinomatosis. Nakagawa H; Murasawa A; Kubo S; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T J Neurooncol; 1992 May; 13(1):81-9. PubMed ID: 1613540 [TBL] [Abstract][Full Text] [Related]
16. Treatment for meningeal carcinomatosis in breast cancer. Yap HY; Yap BS; Rasmussen S; Levens ME; Hortobagyi GN; Blumenschein GR Cancer; 1982 Jul; 50(2):219-22. PubMed ID: 6177395 [TBL] [Abstract][Full Text] [Related]
17. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096 [TBL] [Abstract][Full Text] [Related]
18. Sudden neurologic death after intrathecal methotrexate. Shore T; Barnett MJ; Phillips GL Med Pediatr Oncol; 1990; 18(2):159-61. PubMed ID: 2304423 [TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. Hitchins RN; Bell DR; Woods RL; Levi JA J Clin Oncol; 1987 Oct; 5(10):1655-62. PubMed ID: 3309199 [TBL] [Abstract][Full Text] [Related]
20. Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia. Kim JY; Kim ST; Nam DH; Lee JI; Park K; Kong DS J Korean Neurosurg Soc; 2011 Oct; 50(4):304-10. PubMed ID: 22200011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]